Founder, President & CEO

How to navigate the whisky cask boom

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Associate Director, Commercial Analytics & Reporting

Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. The Associate Director, Commercial Analytics & Reporting will influence strategic commercial decisions through advanced analytics and data-driven insights, focusing on brand performance, forecasting, and market access optimization.

Sign up with Google

Sign in with Google